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Abstract
Background: The usefulness of available vaccine and serological tests for leptospirosis is limited
by the low cross-reactivity of antigens from numerous serovars of pathogenic Leptospira spp.
Identification of genus-specific protein antigens (GP-Ag) of Leptospira would be important for
development of universal vaccines and serodiagnostic methods. OmpL1, a transmembrane porin of
pathogenic leptospires, was identified as a possible GP-Ag, but its sequence diversity and immune
cross-reactivity among different serovars of pathogenic leptospires remains largely unknown.
Results: PCR analysis demonstrated that the ompL1 gene existed in all 15 official Chinese standard
strains as well as 163 clinical strains of pathogenic leptospires isolated in China. In the standard
strains, the ompL1 gene could be divided into three groups (ompL1/1, ompL1/2 and ompL1/3)
according to their sequence identities. Immune electron microscopy demonstrated that all
products of the different gene types of ompL1 are located on the surface of leptospires. The
microscopic agglutination test revealed extensive yet distinct cross-immunoagglutination among
the antisera against recombinant OmpL1 (rOmpL1) and leptospiral strains belonging to different
ompL1 gene types. These cross-immunoreactions were further verified by ELISAs using the OmpL1
proteins as the coated antigens in serum samples from 385 leptospirosis patients. All the antisera
against rOmpL1 proteins could inhibit L. interrogans strain Lai from adhering to J774A.1 cells.
Furthermore, immunization of guinea pigs with each of the rOmpL1 proteins could cause crossimmunoprotection against lethal challenge with leptospires from different ompL1 gene types.
Conclusion: Three types of the ompL1 gene are present in pathogenic leptospires in China.
OmpL1 is an immunoprotective GP-Ag which should be considered in the design of new universal
vaccines and serodiagnostic methods against leptospirosis.
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Background

Results

Leptospirosis, caused by infection with pathogenic Leptospira species belonging to different serogroups and serovars, is one of the most prevalent zoonotic diseases in the
world [1-3]. A wide variety of serogroups and serovars
have been identified along with endemicity which varies
from region to region [4-6]. The leptospiral vaccines used
currently are mainly multivalent dead whole-cell mixtures
made of several local dominant serovars in different countries and regions. These vaccines, however, do not confer
cross-protective immunity to the serogroups that are not
represented in the vaccine [7,8], allowing the unrepresented serovars to continue causing outbreaks of leptospirosis. For instance, in a central province, Anhui, and
an eastern province, Zhejiang, of China, L. interrogans
serogroup Sejroe serovar Medanensis caused local outbreaks of leptospirosis [9-12]. In addition, vaccination
with the whole-cell vaccines may lead to incomplete,
short-term immunity as well as serious side effects [1315]. A universal vaccine against leptospirosis is not available yet, making the identification of genus-specific protein antigens (GP-Ag) that display extensive crossimmunity very valuable for developing new vaccines and
serodiagnostic methods.

Amplification of ompL1 genes in the standard and clinical
strains
All the 15 standard strains and 163 isolates of pathogenic
Leptospira species (Table 1) carried the ompL1 gene, since
amplicons with the expected size were produced by PCR
from all the strains and isolates (data no shown).

Outer membrane proteins (Omps) are important pathogenic components and highly conserved in different serogroups and serovars of pathogenic leptospires. OmpL1, a
transmembrane Omp with 320 amino acid residues, first
reported by Haake and his colleagues in 1993, is a porin
expressed by all the tested pathogenic Leptospira species
[16-19]. However, the diversity of ompL1 gene sequences
from different pathogenic Leptospira spp. and the distribution of the ompL1 gene in clinical isolates had not been
characterized until now. Moreover, the cross-immunogenicity and immunoprotective effects of OmpL1 were
mostly unknown.
In this study, we sequenced and analyzed ompL1 genes
cloned from standard pathogenic strains of leptospires
prevalent in China. Several prokaryotic recombinant
products of the gene (rOmpL1) were expressed and their
rabbit antisera were prepared. rOmpL1-based ELISAs were
established to examine specific antibodies in sera from
leptospirosis patients. In parallel, the microscopic agglutination test (MAT) was performed to detect the crossimmunoagglutination of different antisera against
rOmpL1 proteins, and immunoelectron microscopy
(IEM) was employed to localize OmpL1 on the leptospires. Finally, immunoprotection of rOmpL1 was tested
in guinea pigs. Taken together, our results suggest that
OmpL1 could be used as a major component of a universal and efficient immunogen for vaccination and also for
diagnosis of leptospirosis.

Molecular phylogeny and gene-typing of ompL1 gene
Based on the molecular phylogenetic relationship of their
nucleotide sequences (GenBank Accession No.:
AY622658–AY622672) and putative amino acid
sequences (Figure 1, see Additional file 1 for details),
ompL1 genes from the pathogenic leptospires could be
classified into three groups: ompL1/1, ompL1/2 and ompL1/
3 (Table 2). Sequence identity of the putative amino acid
sequences between ompL1/1 and ompL1/2, ompL1/1 and
ompL1/3, and ompL1/2 and ompL1/3 gene types was
92.50%–93.44%, 85.31%–86.88%, and 85.31%–
86.25%, respectively. In addition, the ompL1 gene
sequencing data of 39 clinical strains also supported the
classification into three groups (Table 2). Both the nucleotide and putative amino acid sequence identities among
the clinical strains with the same ompL1 gene type were
above 98% (data not shown).
Data of secondary structure analysis of OmpL1 proteins
All the three gene types of OmpL1 proteins had very similar predicted secondary structures and antigenic indexes
(Figure 2, see Additional file 2 for details). The OmpL1
proteins had five main putative surface-membrane
regions (70–80, 115–120, 145–150, 235–245, 305–310
amino acid residuals) and seven transmembrane regions
(10–40, 120–130, 160–190, 215–225, 240–250, 270–
280, and 295–305 amino acid residues). The only salient
different was the presence of less alpha-helix in the N-terminal and beta-sheet in the C-terminal region of the
OmpL1/3 sequence, compared to the sequences of
OmpL1/1 and OmpL1/2.
Identification of expressed rOmpL1 proteins and titers of
rabbit antisera
rOmpL1/1, rOmpL1/2 and rOmpL1/3 were well
expressed after induction with IPTG and showed single
bands in gel after purification by Ni-NTA-chromatography (Figure 3). Western blot analysis also indicated that
serum samples from leptospirosis patients could recognize rOmpL1 proteins (Figure 4), implying that the proteins are immunogenic during natural infection.
Immunodiffusion titers of all the rabbit antisera against
rOmpL1 proteins were at least 1:4.
Localization of OmpL1 proteins on leptospires
Using anti-rOmpL1/1, anti-rOmpL1/2 and anti-rOmpL1/
3 sera as the primary antibodies, all the colloidal gold par-
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Table 1: Background information on the leptospiral strains and serum specimens

Strain/Sera
Standard strains (n = 15)
Lai
Lin
Tian
Lin 4
65-9
Luo
Lin 6
P7
L 37
L 183
M 10
Pishu
55-52
Nan 10
L 105
Isolates (n = 163)
85
5
4
18
11
15
20
5
Patient sera (n = 385)
191
11
13
37
31
44
45
13
Normal sera (n = 36)

Serovar

Serogroup

Genospecies

Lai
Canicola
Pyrogenes
Autumnalis
Australis
Pomona
Grippotyphosa
Hebdomadis
Paidjan
Wolffi
Javanica
Ballum
Tarassovi
Mini
Manhao 2

Icterohaemorrhagiae
Canicola
Pyrogenes
Autumnalis
Australis
Pomona
Grippotyphosa
Hebdomadis
Bataviae
Sejroe
Javanica
Ballum
Tarassovi
Mini
Manhao

L. interrogans
L. interrogans
L. interrogans
L. interrogans
L. interrogans
L. interrogans
L. interrogans
L. interrogans
L. interrogans
L. interrogans
L. borgpetersenii
L. borgpetersenii
L. borgpetersenii
L. borgpetersenii
L. weilii

Lai
Canicola
Autumnalis
Pomona
Grippotyphosa
Hebdomadis
Medanesis
Australis

Icterohaemorrhagiae
Canicola
Autumnalis
Pomona
Grippotyphosa
Hebdomadis
Sejroe
Australis

L. interrogans
L. interrogans
L. interrogans
L. interrogans
L. interrogans
L. interrogans
L. interrogans
L. interrogans

Lai
Canicola
Autumnalis
Pomona
Grippotyphosa
Hebdomadis
Medanesis
Australis
/

Icterohaemorrhagia
Canicola
Autumnalis
Pomona
Grippotyphosa
Hebdomadis
Sejroe
Australis
/

L. interrogans
L. interrogans
L. interrogans
L. noguchii
L. interrogans
L. interrogans
L. interrogans
L. interrogans
/

ticles conjugated to secondary antibodies were bound on
the surface of L. interrogans serovar Autumnalis strain Lin
4 (ompL1/1 gene type), serovar Lai strain Lai (ompL1/2
gene type), and L. borgpetersenii serovar Ballum strain
Pishu (ompL1/3 gene type) (Figure 5).
Titers of MAT
The antisera against rOmpL1/1, rOmpL1/2 and rOmpL1/
3 were able to cross-agglutinate with MAT titers of 1:100
to 1:800 for all the 15 standard strains and 163 clinical
strains of pathogenic leptospires (Table 3).
Detection of antibodies against rOmpL1 proteins in
leptospirosis patients
In ELISA assays using rOmpL1/1, rOmpL1/2 and
rOmpL1/3, the positive rates for IgG in specimens from
385 leptospirosis patients using 1:100 and 1:200 serum
dilutions were 87.8% (338/385) and 78.2% (301/385),
95.1% (366/385) and 82.1% (316/385), and 77.7%

(299/385) and 65.5% (252/385), respectively (Table 4).
When using 1:50 and 1:100 serum dilutions from the
same specimens, the positive rates for IgM were 83.4%
(321/385) and 72.7% (280/385), 87.0% (335/385) and
77.4% (298/385), and 74.3% (286/385) and 63.1%
(243/385), respectively (Table 4).
Inhibition of adherence by antisera against rOmpL1
proteins
Anti-rOmpL1/1 (1:200 dilution), anti-rOmpL1/2 (1:300
dilution) or anti-rOmpL1/3 (1:50 dilution) sera could
completely inhibit the adherence of L. interrogans serovar
Lai strain Lai to macrophages (Figure 6), demonstrating
cross-inhibition effects among the different anti-sera.
Immunoprotection due to immunization with rOmpL1
proteins
Immunization of guinea pigs with rOmpL1/1, rOmpL1/2
and rOmpL1/3 conferred a significant level of resistance
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Table 2: ompL1 gene types of standard strains and isolates of Leptospires

Species

Serogroup

Serovar

Strain (n)

ompL1 gene type
1

L. interrogans

Icterohaemorrhagiae

Lai

L. interrogans

Canicola

Canicola

L. interrogans

Australis

Australis

L. interrogans

Pomona

Pomona

L. interrogans

Hebdomadis

Hebdomadis

L. interrogans

Autumnalis

Autumnalis

L. interrogans

Grippotyphosa

Grippotyphosa

L. interrogans

Sejroe

L. interrogans
L. interrogans
L. borgpetersenii
L. borgpetersenii
L. borgpetersenii
L. borgpetersenii
L. weilii

Bataviae
Pyrogenes
Javanica
Ballum
Tarassovi
Mini
Manhao

Wolffi
Medanesis
Paidjan
Pyrogenes
Javanica
Ballum
Tarassovi
Mini
Manhao II

against lethal challenge with pathogenic leptospires from
the three different ompL1 groups (Table 5). However, the
immunoprotective rates against the same ompL1 gene type
leptospiral infection as the immunizing recombinant protein (62.5%–87.5%) were higher than when strains and
proteins from different ompL1 gene types were used
(25.0%–62.5%).

Discussion
Outer membrane proteins exposed on the surface of leptospires are known to react with the host cell and environment. Interestingly, lipopolysaccharide fractions confer
protective immunity against challenge with homologous
but not heterogonous leptospires, whereas protein extract
induced significant protection against both types of challenge [20]. Thus far, a number of outer membrane proteins of leptospires, such as OmpL1, LipL32, LipL36,
LipL41, LigA and LigB, have been cloned and characterized, and some of them have been shown to stimulate
specific immunity in animal models [21-24]. Among all
the leptospiral Omps, OmpL1 is a unique transmembrane
protein that was confirmed to function as a porin, contribute to the survival of leptospires, and display synergetic
immunoprotection with LipL41 [16-18]. However, major
questions such as the distribution of ompL1 gene types in
leptospiral strains, the exact localization of OmpL1, and
cross-immunogenicity and immunoprotective effects of
OmpL1 proteins remain unaddressed.

Lai
Wild (5)
Lin
Wild (5)
65-9
Wild (5)
Luo
Wild (5)
P7
Wild (5)
Lin 4
Wild (4)
Lin 6
Wild (5)
L 183
Wild (5)
L 37
Tian
M 10
Pishu
55-52
Nan 10
L 105

2

3

√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√

This study reveals that the ompL1 gene is present in the
genomes of all the pathogenic leptospires tested. According to our alignment and phylogenetic analysis from the
15 standard strains of pathogenic Leptospira spp., three
groups of ompL1 (ompL1/1, ompL1/2 and ompl/3) exist.
However, the predicted secondary structure of the OmpL1
proteins revealed that there is little difference among the
three groups. Thus, the differences in nucleotide
sequences in the ompL1 gene types may not affect the
immunogenicity and OmpL1 proteins, identifying
OmpL1 as a genus-specific protein antigen.
Surface exposure is a key characteristic for an effective
antigen. Although OmpL1 may be an outer membrane
protein according to previous reports, the precise localization of OmpL1 still remained unclear. Leptospires possess
both inner and outer membranes, but only the proteins
expressed in the outer membrane are capable of interacting with the host immune system. To begin to characterize
the localization, we used the prokaryotic recombinant
expression technique to obtain a large amount of homogeneous OmpL1 proteins for preparation of immunoresponsive antisera from rabbits. Visualization by immunoelectron microscopy using anti-OmpL1 anti-sera confirmed that OmpL1 is located at the surface of the outer
membrane of leptospires. MAT is a standard method for
serodiagnosis of leptospirosis and serological classification of leptospires, for which live leptospiral cells are typ-
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Figure
(A)
Maximum
and 1
itsparsimony
amino acidtrees
sequences
for ompL1
(B) ofnucleotide
15 standard
sequences
strains
Maximum parsimony trees for ompL1 nucleotide
sequences (A) and its amino acid sequences (B) of 15
standard strains. This figure shows the upper quartile, for
the full image please see Additional file 1. The numbers at
each fork node indicate the bootstrapping values (shown
only when > 50%). RefSeq accession number and abbreviation for the organism are shown at each relevant branch. The
scale bar indicates the number of character substitutions.

ically used [23]. In this study, we used MAT to examine
cross-immunoagglutination among the antisera from
rOmpL1 proteins and a large number of strains belonging
to different pathogenic leptospiral serogroups/serovars.
The results indicated that there is extensive cross-immunoagglutination between the different ompL1 gene types
of pathogenic leptospiral strains and the OmpL1 antisera,
and not surprisingly, the highest agglutination was
observed between antisera from the same ompL1 gene
types as the leptospiral strains. Furthermore, ELISA results
revealed that OmpL1s-specific antibodies are produced in
all the sera from leptospirosis patients, and the trends in
cross-immunoreactivities in the different ELISA tests are
also similar to those of MAT.
At least 75 serovars of pathogenic leptospires belonging to
18 serogroups have been found to date in China, but only
a few of them frequently cause leptospirosis. According to
the annual reports on leptospirosis from Chinese CDCs,
L. interrogans serogroup Icterohaemorrhagiae serovar Lai
is the most dominant pathogenic leptospires, responsible
for approximately 75% of the morbidity in the country.
The other pathogenic leptospires causing leptospirosis are
the Grippotyphosa, Autumnalis, Australis, Pomona and

http://www.biomedcentral.com/1471-2180/8/223

Figure
Comparison
genic
index
2 ofofOmpL1
the predicted
proteins
secondary structures and antiComparison of the predicted secondary structures
and antigenic index of OmpL1 proteins. This figure
shows the upper quartile, for the full image please see Additional file 2. The related strains of the same gene type just
show the same predicted structure topology. Thus, only the
results from three representative strains are showed here.

Hebdomadis serovars [3,11,25]. Our study showed that
all the 163 clinical strains of different pathogenic Leptospiral serogroup/serovars belong to either the ompL1/1
or ompL1/2 group (data not shown). Thus, we conclude
that leptospires from the ompL1/1 and ompL1/2 groups are
the most prevalent strains in China.
In this study, immunization with either rOmpL1/1,
rOmpL1/2 or rOmpL1/3 proteins could enhance significantly survival of guinea pigs lethally challenged with
pathogenic Leptospira species (Table 5). The immunoprotective rates in the groups, in which animals received a
rOmpL1 for immunization and challenge with the same
ompL1 gene type, appeared to be higher than those being
challenged with different ompL1 gene types.
In a previous study [35], we found L. interrogans serovar
Lai strain Lai could adhere to macrophages, and we here
show that adherence to macrophages could be blocked
with antisera against any of the rOmpL1 proteins, confirming cross-immunogenicity of OmpL1 proteins from
the three different groups. All these data collectively suggest that OmpL1 is likely a genus-specific antigen.
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Figure 3 and purification of recombinant OmpL1 proteins
Expression
Expression and purification of recombinant OmpL1 proteins. Lanes 1 and 6: protein markers (BioColor); lane 2:
pET42a with no inserted ompL1 genes; lanes 3 to 5: the expressed rOmpL1/1, rOmpL1/2 and rOmpL1/3, respectively; lanes 7
to 9: the purified rOmpL1/1, rOmpL1/2 and rOmpL1/3, respectively.

Conclusion
OmpL1 is a transmembrane protein extensively expressed
in pathogenic leptospires. Although the ompL1 gene can
belong to any of three different gene types, the OmpL1
proteins expressed by different gene types have conserved
immunogenicity and the specific antibodies generally
exist in sera of leptospirosis patients. OmpL1 should thus
be viewed as a potential candidate of genus-specific antigen for the development of new universal vaccines and
serodiagnostic methods for leptospirosis.

Methods
Leptospiral strains and serum specimens
The National Institute for the Control of Pharmaceutical
and Biological Products (NICPBP) in Beijing, China, pro-

vided all 15 official Chinese standard strains belonging to
fifteen different pathogenic serogroups of Leptospira. In
addition, 163 clinical pathogenic Leptospiral isolates and
385 serum specimens from leptospirosis patients with
MAT titers of ≥ 1:100 were provided by the Centers of Disease Prevention and Control of Sichuan, Anhui and Zhejiang provinces in China during 2004–2007 (Table 1). All
the leptospiral strains were cultured in liquid Korthof
medium containing 8% rabbit serum at 28°C [2,25]. All
the patients were clinically diagnosed suffering from acute
leptospirosis based on their medical history and clinical
symptoms, including fevers, jaundice, hemorrhaging,
myalgia and lymphadenectasis, as well as laboratory
examination. Finally, 36 sera samples with negative
results by MAT from healthy individuals for routine soma-

Figure 4 of purified rOmpL1 proteins by sera from leptospirosis patients
Recognition
Recognition of purified rOmpL1 proteins by sera from leptospirosis patients. Lane 1: protein markers (BioColor);
lanes 2–13: the rOmpL1/1, rOmpL1/2 and rOmpL1/3 hybridizing with the antisera from leptospirosis patients; lane 13: normal
human serum used as control.
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Figure
The
localization
5
of OmpL1 on the surface of leptospires
The localization of OmpL1 on the surface of leptospires. A: negative control; B to D: the immunogold particles binding
to OmpL1/1, OmpL1/2 and OmpL1/3 on the surface of L. interrogans serovar Autumnalis strain Lin 4, serovar Lai strain Lai, and
L. borgpetersenii serovars Ballum strain Pishu, respectively.
toscopy were offered by the First Affiliated Hospital of
Zhejiang University. Informed written consent for sample
collection was obtained from all participants and individuals with ethical approval from the Ethics Committee of
Zhejiang University. This research was conducted in
accordance with the Declaration of Helsinki and with the
Guide for Care and Use of Laboratory Animals as adopted
and promulgated by the United States National Institutes

of Health. All experimental protocols were approved by
the Ethics Committee of Zhejiang University.
Cell line and cell culture
The murine monocyte/macrophage-like cell line, J774A.1,
was provided by the Cell Bank of the Institute of Cell Biology in Shanghai, Chinese Academy of Science, and was
maintained in RPMI 1640 medium (GiBco, Grand Island,
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Table 3: MAT titers among anti-rOmpL1 antisera and 178 leptospiral strains

Strain

Standards (n = 15)
Lai
M 10
Lin
Pishu
Tian
Lin 4
65-9
Luo
Lin 6
P7
L 37
55-52
L 105
L 183
Nan 10
Isolates (n = 163)
85
5
4
5
18
11
15
20

Serovar

Lai
Javanica
Canicola
Ballum
Pyrogenes
Autumnalis
Australis
Pomona
Grippotyphosa
Hebdomadis
Paidjan
Tarassovi
Manhao II
Wolffi
Mini

Gene type

2
3
2
3
3
1
2
2
1
2
2
3
2
1
3

Lai
Canicola
Autumnalis
Australis
Pomona
Grippotyphosa
Hebdomadis
Medanesis

USA) supplemented with 10% fetal bovine serum (FBS)
(GiBco), and 100 U/ml penicillin and 100 μg/ml streptomycin. The cells were cultured in 5% CO2 at 37°C.
Amplification and sequencing of ompL1 genes
Leptospiral DNA was extracted using Bacterial Genomic
DNA Extraction Kit (BioColor BioScience & Technology
Co., Shanghai, China) and then dissolved in TE buffer.
Density and purity of the extracted DNAs were detected by
UV spectrophotometery. One pair of primers was applied
to amplify the entire ompL1 gene. The upstream primer
was 5'-CCG CATATG (Nde I) ATC CGT AAC ATA AGT
AAG-3' and the downstream primer was 5'-CCG CTCGAG
(Xho I) GAG TTC GTG TTT ATA ACC-3'. A High Fidelity
PCR Kit (TaKaRa, Dalian, China), in which Taq-Pfu mixture is used as DNA polymerase, was used to amplify the
target gene. The total volume per PCR was 50 μl which
included 20 pmol of each of the primers, 2.5 U Taq-Pfu
DNA polymerase, and 100 ng DNA templates. The reaction mixture was initiated by incubation at 94°C for 5
min, followed by 30 cycles of amplification at 94°C for 30
s, 55°C for 30 s and 72°C for 90 s, and then incubation at
72°C for 10 min. The products were detected in 1.5%
ethidium bromide pre-stained agarose gel by agarose electrophoresis. The target products were predicted to be 960
base pairs (bp) in size. To obtain more accurate sequence

MAT titer (1:xxx)
Anti-OmpL1/1

Anti-OmpL1/2

Anti-OmpL1/3

400
100
200
100
100
400
200
200
400
200
200
100
200
400
100

400
100
400
200
100
400
400
400
400
400
400
200
400
200
100

200
400
100
400
400
200
100
100
200
100
100
400
100
100
200

200~400
200
400
200
200~400
400~800
200~400
400

200~800
400
200~400
400
200~800
200~400
200~800
200~400

100~200
100
100
100
100~200
100~200
100~200
100~200

data, the PCR products were purified using PCR Products
Purification Kit (BioColor) and then ligated into plasmid
pMD 18-T using T-A Cloning Kit (TaKaRa) [26]. The
cloned ompL1 genes of 15 standard strains and 39 clinical
strains were sequenced by Invitrogen (Shanghai, China).
Phylogenetic analysis and secondary structure prediction
of OmpL1 protein
The similarity and homology of sequences were first evaluated with the BLASTN program of NCBI. Alignments
were carried out using ClustalX 1.83 software [27] and
manually adjusted using GeneDoc 2.7 software. The
amino acid sequences were deduced from their nucleotide
sequences. Phylogenetic analysis was carried out with
Maximum Parsimony (MP) and Maximum Likelihood
(ML) optimality criteria of the PAUP* package (Version
4.0b10) [28] and MEGA 3.1 software [29]. And the probability prediction for secondary structures [30,31], including antigenic analysis [32] of OmpL1 proteins, was
computed using the protean program in DNAStar™ software package.
Prokaryotic expression and preparation of antisera
against OmpL1 proteins
The recombinant plasmids pMD18-T-ompL1/1/2/3 as well
as vector pET42a (Novagen, USA) were respectively
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Table 4: ELISA detection of rOmpL1-IgG/IgM in sera of leptospirosis patients

Sera

Cases (n)

Patients infected with:
Icterohaemorrhagia

191

Canicola

11

Autumnalis

13

Pomona

44

Australis

13

Grippotyphosa

31

Hebdomadis

37

Sejroe

45

Total

385

Healthy individuals:

36

Dilution (1:xxx)

50
100
200
50
100
200
50
100
200
50
100
200
50
100
200
50
100
200
50
100
200
50
100
200
50
100
200
50
Cut-off
100
Cut-off
200
Cut-off

IgG-ELISA positive (n)

IgM-ELISA positive (n)

rOmpL1/1

rOmpL1/2

rOmpL1/3

rOMPL1/1

rOMPL1/2

rOMPL1/3

/
159
147
/
10
8
/
13
12
/
38
33
/
12
10
/
30
26
/
33
28
/
43
37
/
338
301
/
/
0.17 ± 0.05
0.32
0.14 ± 0.04
0.26

/
187
162
/
11
10
/
12
9
/
43
37
/
13
11
/
26
23
/
36
31
/
38
33
/
366
316
/
/
0.18 ± 0.05
0.33
0.13 ± 0.05
0.28

/
149
135
/
9
6
/
10
7
/
33
27
/
10
8
/
23
16
/
30
24
/
35
29
/
299
252
/
/
0.17 ± 0.06
0.35
0.15 ± 0.04
0.27

145
132
/
9
8
/
13
10
/
38
31
/
12
10
/
29
23
/
34
29
/
41
37
/
321
280
/
0.20 ± 0.06
0.38
0.18 ± 0.05
0.33
/
/

161
152
/
11
9
/
11
8
/
41
35
/
13
11
/
26
21
/
35
30
/
37
32
/
335
298
/
0.20 ± 0.07
0.41
0.17 ± 0.06
0.35
/
/

139
128
/
9
6
/
9
7
/
31
26
/
10
7
/
22
16
/
30
25
/
36
28
/
286
243
/
0.19 ± 0.07
0.40
0.17 ± 0.05
0.32
/
/

Note: the mean at OD490 + 3 SD = cut-off value

digested with Nde I and Xho I (TaKaRa). The recovered
ompL1 segments were respectively linked with the linearized pET42a by T4 DNA ligase (TaKaRa) and then transformed into E. coli BL21DE3 (Novagen). The three
constructed prokaryotic expression systems were induced
with 0.5 mM IPTG in LB medium to express recombinant
OmpL1 (rOmpL1). Expression of rOmpL1 was examined
by SDS-PAGE plus Gel Image Analyzor (BioRad, USA).
The expressed rOmpL1 proteins were extracted and purified by Ni-NTA affinity chromatography. New Zealand
white Rabbits provided by the Laboratory Animal Center,
Zhejiang University, were immunized intradermally with
each of the purified rOmpL1 proteins pre-mixed with Freund's adjuvant for four times at an interval of once a week.
On the 15th day after the last immunization, the rabbit
sera were collected and the Immunodiffusion test was
used to examine the titers of antisera [24].

Western blot assay
Western blot analysis was used to identify the immunoreactivity of rOmpL1 proteins using 12 serum samples from
the patients diluted at 1:1000 (the same dilution of normal human sera was used as control) as the primary antibodies, and 1:3000 diluted HRP-labeled goat anti-human
IgG (Jackson ImmunoResearch Laboratories Inc., USA) as
the secondary antibody.
Immuno-electron microscopy
Freshly-cultured L. interrogans serovar Autumnalis strain
Lin 4 (ompL1/1 gene type), serovar Lai strain Lai (ompL1/2
gene type), and L. borgpetersenii serovar Ballum strain
Pishu (ompL1/3 gene type) were centrifuged at 12, 000
rpm for 15 min at 15°C. The precipitates were fixed with
fresh 2% paraformaldehyde at 4°C for 24 h. Prepared sections were exposed to 5% FBS at room temperature for 30
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Figure 6 of leptospiral adherence to J744A.1 macrophages in the presence anti-rOmpL1 antiserum
Inhibition
Inhibition of leptospiral adherence to J744A.1 macrophages in the presence anti-rOmpL1 antiserum. A: Leptospires binding to macrophages in the presence of irrelevant antisera. B: inhibition of leptospiral binding to macrophages in the
presence of antiserum against recombinant OmpL1 protein (amplification ×1000).
min to block unspecific antigens, and then incubated with
each 1:1000 diluted rOmpL1s rabbit antisera or preimmune normal rabbit sera (negative control) as the first
antibody and 1:2000 diluted colloidal gold (12 nm)labeled goat anti-rabbit IgG (Jackson ImmunoResearch
Laboratories) as the second antibody. The locations of
OmpL1s were determined under transmission electron

microscope
land)[16].

(Philips

TECNAL-10,

Eindhoven,

Hol-

Microscopic agglutination test
The microscopic agglutination test (MAT) was used to
determine cross-immunoagglutination under dark-field
microscopy using rabbit antisera against the rOmpL1 proteins reacting with the 15 freshly-cultured standard strains

Table 5: Immunoprotective effects of rOmpL1 proteins in guinea pigs

Group

A1
A2
A3
A4
A5
A6
B1
B2
B3
B4
B5
B6
C1
C2
C3
C4
C5
C6
D1
D2
D3

Animals (n)

8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8

Immunizing dosage (mg/kg)

Infecting Leptospiral

Survival/Death

Protective rate

rOmpL1/1

rOmpL1/2

rOmpL/3

strain

(n/n)

(%)

1.0
2.0
1.0
2.0
1.0
2.0
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/

/
/
/
/
/
/
1.0
2.0
1.0
2.0
1.0
2.0
/
/
/
/
/
/
/
/
/

/
/
/
/
/
/
/
/
/
/
/
/
1.0
2.0
1.0
2.0
1.0
2.0
/
/
/

Lai
Lai
Lin 4
Lin 4
Pishu
Pishu
Lai
Lai
Lin 4
Lin 4
Pishu
Pishu
Lai
Lai
Lin 4
Lin 4
Pishu
Pishu
Lai
Lin 4
Pishu

3/5
5/3
5/3
7/1
2/6
3/5
5/3
6/2
4/4
5/3
2/6
3/5
2/6
3/5
3/5
4/4
5/3
6/2
0/8
0/8
0/8

37.5
62.5
62.5
87.5
25.0
37.5
62.5
75.0
50.0
62.5
25.0
37.5
25.0
37.5
37.5
50.0
62.5
75.0
/
/
/
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and 163 clinical isolates of leptospires, in which normal
saline was used as negative control [2,33].
ELISA assay with rOmpL1 proteins
Enzyme-linked immunosorbent assays (ELISAs) were
used to detect rOmpL1/1 or rOmpL1/2-specific IgM or
IgG. Briefly, 96-well plates were coated with 50 μg/ml
rOmpL1/1 or rOmpL1/2 (100 μl per well) at 4°C overnight, and then incubated with 5% FBS for 30 min to
block unspecific binding. Using the diluted serum specimens from patients or normal individuals (1:50 or 1:100
dilution for IgM detection, and 1:100 or 1:200 dilution
for IgG detection) as the primary antibody, HRP-labeling
goat anti-human IgM (1:3000 dilution) or IgG (1:4000
dilution) (Jackson ImmunoResearch Laboratories) as the
secondary antibody, and o-phenvlenediamine (OPD) as
the substrate, the rOmpL1 proteins-specific IgM or IgG
were examined under a Microplate Reader (Model 550,
BioRad). OD490 values over the mean plus 3 SD of the 36
normal serum specimens were defined as positive [34].
Adherence inhibition test
J774A.1 cells (1 × 105 cells in 1 ml medium per well) were
inoculated in 12-well plates (Corning, USA) containing
glass cover slips, incubated at 37°C for 24 h. Freshlygrown cultures of L. interrogans serovar Lai strain Lai were
centrifuged at 10,000 rpm for 15 min at 15°C, and the
precipitates were then suspended in antibiotics-free RPMI
1640 medium (GiBco) to a final concentration of 108/ml.
The antisera against rOmpL1 proteins were serially double-diluted with antibiotics-free RPMI 1640 medium (1:2
to 1:32), then mixed with the same volumes of each leptospiral suspension. The mixtures were incubated at 37°C
for 1 h. The medium in the 12-well plates was removed,
and then the plates were repeatedly washed with antibiotic-free RPMI1640 medium. The mixtures were added
into the plates to incubate at 37°C for 1 h. After the incubation, the plates were repeatedly washed with PBS to
remove non-adhered leptospires, and the Fontana silverstained leptospires adhering J774A.1 cells were observed
under light microscope [35]. In this test, preimmune rabbit serum instead of the antisera was used as control.
Immunoprotective test in guinea pigs
Dunkin-Hartley guinea pigs (150 ± 5 g, 3 weeks old) used
in this study were provided by Laboratory Animal Center
of Zhejiang University (certificate no. SCXK [zhe]20070030). L. interrogans serovar Lai strain Lai, serovar Autumnalis strain Lin 4, and L. borgpetersenii serovar Bullum
stain Pishu were maintained by serial passage in guinea
pigs for preservation of virulence before use for challenge.
Eighteen groups of guinea pigs (A1–6, B1–6, and C1–C6)
were subcutaneously immunized twice at an interval of
once a week with different dosages of rOmpL1/1,
rOmpL1/2 and rOmpL1/3, respectively. In addition,

http://www.biomedcentral.com/1471-2180/8/223

another three groups of guinea pigs (D1-3) were immunized with bovine serum albumin (BSA) (Sigma, USA) as
control. Each protein antigen was pre-mixed with 0.7 mg
aluminum hydroxide (Sigma) [36]. On the 15th day after
the last immunization, the animals were challenged intraperitoneally with lethal doses of strain Lai, strain Lin 4 or
strain Pishu and then observed for another 7 days.

Authors' contributions
HD carried out the molecular genetic studies, immunoassays, drafted the manuscript. YH: carried out the
immunoelectron microscope assay. FX carried out the bioinformatics analysis and immunoprotective test. JM carried out the immunoassays, cultured the leptospires. DS
participated in the design of the study, analysis and interpretation of data. DO participated in study design and
coordination, revised the manuscript. JY conceived of the
study, and participated in its design and coordination. All
authors read and approved the final manuscript, agreed to
be published.

Additional material
Additional file 1
Full image of maximum parsimony trees for ompL1 nucleotide
sequences (A) and its amino acid sequences (B) of 15 standard
strains. This figure showed the phylogenetic relationship of nucleotide
sequence and amino acid sequences of Chinese 15 standard strains of
pathogenic leptospires.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712180-8-223-S1.tiff]

Additional file 2
Full image of comparison of the predicted secondary structures and
antigenic index of OmpL1 proteins. This figure showed the predicted secondary structures and antigenic index of OmpL1 proteins belongs to three
gene types (ompL1/1, ompL1/2, and ompL1/3).
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712180-8-223-S2.tiff]

Acknowledgements
This work was supported by Key Science and Technique Plan project of
Zhejiang Province, China (Grant No. 2006C24003) and National science
and technology Key program of China (Grant No. 2008ZX10404). We
thank the CDCs of China for providing the clinical strains of pathogenic
leptospires and serum specimens from leptospirosis patients.

References
1.
2.
3.
4.

Levett PN: Leptospirosis. Clin Microbiol Rev 2001, 14:296-326.
Faine S, Adher B, Bloin C, Perolat P: Leptospira and leptospirosis.
2nd edition. Melbourne, Australia: MedSci; 1999.
McBride AJ, Athanazio DA, Reis MG, Ko AI: Leptospirosis. Curr
Opin Infect Dis 2005, 18:376-386.
Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA,
Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM, Peru-United

Page 11 of 12
(page number not for citation purposes)

BMC Microbiology 2008, 8:223

5.
6.

7.
8.
9.

10.
11.

12.
13.

14.

15.
16.

17.

18.

19.

20.
21.
22.
23.
24.

25.

States Leptospirosis Consortium: Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003, 3:757-771.
Pappas G, Papadimitriou P, Siozopoulou V, Christou L, Akritidis N:
The globalization of leptospirosis: worldwide incidence
trends. Int J Infect Dis 2008, 12:351-357.
Sejvar J, Bancroft E, Winthrop K, Bettinger J, Bajani M, Bragg S, Shutt
K, Kaiser R, Marano N, Popovic T, Tappero J, Ashford D, Mascola L,
Vugia D, Perkins B, Rosenstein N, Eco-Challenge Investigation Team:
Leptospirosis in "Eco-Challenge" athletes, Malaysian Borneo, 2000. Emerg Infect Dis 2003, 9:702-707.
Sonrier C, Branger C, Michel V, Ruvoën-Clouet N, Ganière JP, AndréFontaine G: Evidence of cross-protection within Leptospira
interrogans in an experimental model. Vaccine 2000, 19:86-94.
Koizumi N, Watanabe H: Leptospirosis vaccines: past, present,
and future. J Postgrad Med 2005, 51:210-214.
Campagnolo ER, Warwick MC, Marx HL Jr, Cowart RP, Donnell HD
Jr, Bajani MD, Bragg SL, Esteban JE, Alt DP, Tappero JW, Bolin CA,
Ashford DA: Analysis of the 1998 outbreak of leptospirosis in
Missouri in humans exposed to infected swine. J Am Vet Med
Assoc 2000, 216:676-682.
Venkataraman KS, Nedunchelliyan S: Epidemiology of an outbreak of leptospirosis in man and dog. Comp Immunol Microbiol
Infect Dis 1992, 15:243-247.
Gong ZY, Jiang LP, Chen EF, Wang Z, Li JF, Fu GM, Cai CL, Xu FH:
Epidemiological surveillance of leptospirosis in 1997–2002 in
Zhejiang Province. Zhonghua Liu Xing Bing Xue Za Zhi 2004,
25:1091.
Shi MH, Tu YR, Li QJ: Study on geographical distribution of
leptospirosis in China. Zhonghua Liu Xing Bing Xue Za Zhi 1995,
16:259-62.
Martinez R, Perez A, Quinones Mdel C, Cruz R, Alvarez A, Armesto
M, Fernández C, Menéndez J, Rodríguez I, Baró M, Díaz M, Rodríguez
J, Sierra G, Obregón AM, Toledo ME, Fernández N: Efficacy and
safety of a vaccine against human leptospirosis in Cuba. Rev
Panam Salud Publica 2004, 15:249-255.
Yan Y, Chen Y, Liou W, Ding J, Chen J, Zhang J, Zhang A, Zhou W,
Gao Z, Ye X, Xiao Y: An evaluation of the serological and epidemiological effects of the outer envelope vaccine to Leptospira . J Chin Med Assoc 2003, 66:224-230.
Rathinam SR: Ocular leptospirosis. Curr Opin Ophthalmol 2002,
13:381-386.
Haake DA, Champion CI, Marfinich C, Shang ES, Blanco DR, Miller JN,
Lovett MA: Molecular cloning and sequence analysis of the
gene encoding OmpL1, a transmembrane outer membrane
protein of pathogenic Leptospira spp.
J Bacteriol 1993,
175(13):4225-4234.
Shang ES, Exner MM, Summers TA, Martinich C, Champion CI, Hancock RE, Haake DA: The rare outer membrane protein,
OmpL1, of pathogenic Leptospira species is a heat-modifiable porin. Infect Immun 1995, 63:3174-3181.
Haake DA, Mazel MK, McCoy AM, Milward F, Chao G, Matsunaga J,
Wagar EA: Leptospiral outer membrane proteins OmpL1 and
LipL41 exhibit synergistic immunoprotection. Infect Immun
1999, 67:6572-6582.
Haake DA, Suchard MA, Kelley MM, Dundoo M, Alt DP, Zuerner RL:
Molecular evolution and mosicism of leptospiral outer membrane proteins involves horizontal DNA transfer. J Bateriol
2004, 186:2818-2128.
Sonrier C, Branger C, Michel V, Ruvoën-Clouet N, Ganière JP, AndréFontaine G: Evidence of cross-protection within Leptospira
interrogans in an experimental model. Vaccine 2000, 19:86-94.
Cullen PA, Cordwell SJ, Bulach DM, Haake DA, Adler B: Global
analysis of outer membraneproteins from Leptospira interrogans serovar Lai. Infect Immun 2002, 70:2311-2318.
Cullen PA, Haake DA, Adler B: Outer membrane proteins of
pathogenic spirochetes. FEMS Microbiol Rev 2004, 28:291-318.
Palaniappan RU, Ramanujam S, Chang YF: Leptospirosis: pathogenesis, immunity, and diagnosis. Curr Opin Infect Dis 2007,
20:284-292.
Zhang XY, Yu Y, He P, Zhang YX, Hu BY, Yang Y, Nie YX, Jiang XG,
Zhao GP, Guo XK: Expression and comparative analysis of
genes encoding outer membrane proteins LipL21, LipL32
and OmpL1 in epidemic leptospires. Acta Biochim Biophys Sin
2005, 37:649-656.
Dai B: Advances in research on leptospira and human leptospirosis in China. Chin Med Sci J 1992, 7:239-43.

http://www.biomedcentral.com/1471-2180/8/223

26.
27.

28.
29.
30.
31.
32.
33.
34.
35.

36.

Kobayashi Y: Clinical observation and treatment of leptospirosis. J Infect Chemother 2001, 7:59-68.
Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG: The
Clustsal X windows interface: flexible strategies for multiple
sequence alignment aided by quality analysis tools. Nucleic
Acids Res 1997, 24:4876-4882.
Swofford DL: PAUP *: Phylogenetic analysis using parsimony
(*and other methods). Sunderland, Massachusetts, USA: Sinauer
Associates; 2002.
Kumar S, Tamura K, Nei M: MEGA3: Integrated software for
Molecular Evolutionary Genetics Analysis and sequence
alignment. Brief Bioinform 2004, 5:150-163.
Chou PY, Fasman GD: Prediction of secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas
Mol Biol 1978, 47:145-148.
Kyte J, Doolittle RF: A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982, 157:105-132.
Jameson BA, Wolf H: The antigenic index: a novel algorithm for
predicting antigenic determinants. Comput Appl Biosci 1988,
4:181-186.
Sambrook J, Fritsch EF, Maniatis T: Molecular cloning, a laboratory manual. New York, USA: Cold Spring Harbor Laboratory
Press; 1989.
Lewis SM, Osei-Bimpong A: Haemoglobinometry in general
practice. Clin Lab Haematol 2003, 25:343-346.
Li L, Ojcius DM, Yan J: Comparison of invasion of fibroblasts
and macrophages by high- and low-virulence Leptospira
strains: colonization of the host-cell nucleus and induction of
necrosis by the virulent strain. Arch Microbiol 2007, 188:591-598.
Levesque PM, Foster K, de Alwis U: Association between immunogenicity and adsorption of a recombinant Streptococcus
pneumomiae vaccine antigen by aluminum adjuvant. Hum
Vaccin 2006, 2(2):74-77.

Publish with Bio Med Central and every
scientist can read your work free of charge
"BioMed Central will be the most significant development for
disseminating the results of biomedical researc h in our lifetime."
Sir Paul Nurse, Cancer Research UK

Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central
yours — you keep the copyright

BioMedcentral

Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp

Page 12 of 12
(page number not for citation purposes)

